Literature DB >> 6601908

Cerebral cortical atrophy in pediatric patients with end-stage renal disease.

H W Schnaper, B R Cole, F J Hodges, A M Robson.   

Abstract

Computed tomography of the head in 15 children with end-stage renal disease revealed cerebral cortical atrophy in eight and ventricular enlargement in an additional two. These changes were not necessarily associated with any clinical signs or symptoms. Although high doses of steroids may have been responsible for some of the lesions, alternate etiologies are required to explain the abnormality in others cases. The mean length of time the patients received chronic hemodialysis was twice as long in patients with atrophy as in those with normal scans. However, possible causative factor/s related to dialysis could not be identified. The high incidence of cerebral atrophy is cause for concern and indicates the need for further study of this phenomenon.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601908     DOI: 10.1016/s0272-6386(83)80046-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  10 in total

1.  Hemiparesis in a girl with cystinosis and renal transplant.

Authors:  A Van Lierde; D Colombo; L N Rossi; F Marchesi; M Giani; G Consalvo; A Edefonti; L Ghio
Journal:  Eur J Pediatr       Date:  1994-09       Impact factor: 3.183

2.  Brain Magnetic Resonance Imaging Findings in Children and Young Adults With CKD.

Authors:  Erum A Hartung; Guray Erus; Abbas F Jawad; Nina Laney; Jimit J Doshi; Stephen R Hooper; Jerilynn Radcliffe; Christos Davatzikos; Susan L Furth
Journal:  Am J Kidney Dis       Date:  2018-02-15       Impact factor: 8.860

3.  Complications of nephropathic cystinosis after renal failure.

Authors:  W A Gahl; M I Kaiser-Kupfer
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

4.  Unexpected seizures during hemodialysis. Effect of dialysate prescription.

Authors:  D M Ford; R J Portman; D L Hurst; G M Lum
Journal:  Pediatr Nephrol       Date:  1987-10       Impact factor: 3.714

Review 5.  Systematic review of structural and functional neuroimaging findings in children and adults with CKD.

Authors:  Divya G Moodalbail; Kathryn A Reiser; John A Detre; Robert T Schultz; John D Herrington; Christos Davatzikos; Jimit J Doshi; Guray Erus; Hua-Shan Liu; Jerilynn Radcliffe; Susan L Furth; Stephen R Hooper
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-30       Impact factor: 8.237

6.  Duration of chronic kidney disease reduces attention and executive function in pediatric patients.

Authors:  Susan R Mendley; Matthew B Matheson; Shlomo Shinnar; Marc B Lande; Arlene C Gerson; Robert W Butler; Bradley A Warady; Susan L Furth; Stephen R Hooper
Journal:  Kidney Int       Date:  2014-09-24       Impact factor: 10.612

7.  Design and methods of the NiCK study: neurocognitive assessment and magnetic resonance imaging analysis of children and young adults with chronic kidney disease.

Authors:  Erum A Hartung; Nina Laney; Ji Young Kim; Rebecca L Ruebner; John A Detre; Hua-Shan Liu; Christos Davatzikos; Guray Erus; Jimit J Doshi; Robert T Schultz; John D Herrington; Abbas F Jawad; Divya G Moodalbail; Ruben C Gur; Allison M Port; Jerilynn Radcliffe; Stephen R Hooper; Susan L Furth
Journal:  BMC Nephrol       Date:  2015-04-30       Impact factor: 2.388

Review 8.  Impact of Chronic Kidney Disease on Brain Structure and Function.

Authors:  Emily J Steinbach; Lyndsay A Harshman
Journal:  Front Neurol       Date:  2022-02-25       Impact factor: 4.003

9.  Brain abnormalities in children and adolescents with chronic kidney disease.

Authors:  Mina Matsuda-Abedini; Kevin Fitzpatrick; Waverly R Harrell; Debbie S Gipson; Stephen R Hooper; Aysenil Belger; Ken Poskitt; Steven P Miller; Bruce H Bjornson
Journal:  Pediatr Res       Date:  2018-07-02       Impact factor: 3.756

Review 10.  The central nervous system in childhood chronic kidney disease.

Authors:  Debbie S Gipson; Peter J Duquette; Phil F Icard; Stephen R Hooper
Journal:  Pediatr Nephrol       Date:  2006-10-27       Impact factor: 3.714

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.